EOLS
Evolus, Inc. Common StockstockNASDAQ
At CloseNov 19, 2026 4:00:00 PM EST
6.99USD-1.132%(-0.08)870,976
After-hoursNov 19, 2026 4:00:30 PM EST
7.00USD+0.143%(+0.01)
Loading…
Loading…
462.66M
Healthcare
Drug Manufacturers-Specialty & Generic
CEO
David Moatazedi
HQ
Newport Beach, CA, USA
Previous Close
$7.07
Beta
1.34
52-Week High
$9.31 2026-09-04
52-Week Low
$3.86 2026-03-30
SMA 50
$7.47
SMA 200
$6.41
Avg. Vol 10D
1.40M
Avg. Vol 30D
974,396
Avg. Vol 90D
924,972
Relative Vol
0.89
66.19M
47.66M
72.01%
6,023,009
12.10%
9.38
50%/50%
52.94%
37.07%
0.4300%
5,500,000
305,717
65,634
305,717
325.5M
-31.1M
-0.47
-4.9M
-4.79
93.47
Nov 12, 2026
Nov 11, 2026
Nov 5, 2026
Evolus (EOLS) Q3 2026 Earnings Call Transcript ·
The Motley Fool+1 source
EOLS Profile
evolus, inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the united states. it offers jeuveau, a proprietary 900 kilodalton purified botulinum toxin type a formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. the company was founded in 2012 and is headquartered in newport beach, california.
EOLS Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 6.96 | 2026-11-13 | +0.43% | 5.025 |
| 1M | 7.37 | 2026-10-20 | -5.16% | 1.967 |
| 3M | 8.35 | 2026-08-20 | -16.29% | 1.753 |
| 6M | 6.59 | 2026-05-20 | +6.07% | 1.009 |
| 1Y | 6.62 | 2025-11-20 | +5.59% | 1.337 |
| 2Y | 12.63 | 2024-11-20 | -44.66% | — |
| 5Y | 6.38 | 2021-11-19 | +9.56% | 1.087 |
EOLS Stock Summary
Evolus, Inc. Common Stock (NASDAQ:EOLS) stock price today is $6.99, and today's volume is 870,976. EOLS is down 1.132% today. The 30 day average volume is 974,396. EOLS market cap is $462.66M with 66.19M shares outstanding.